**Author details**

Amin Amer\*, Mohamed Amer and Hagar Nofal\* Dermatology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

\*Address all correspondence to: aminamer74@gmail.com and hnofal@medicine.zu.edu.eg

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**39**

*Botulinum Toxin for the Face*

1;76(6):1013-1024.

**References**

[1] Giordano CN, Matarasso SL, Ozog DM. Injectable and topical neurotoxins in dermatology: Basic science, anatomy, and therapeutic agents. J Am Acad Dermatol. 2017 Jun

[2] Trindade de Almeida AR, Montagner S. Botulinum Toxin for Axillary Hyperhidrosis. Hyperhidrosis.

2014 Oct 1;32(4):495-504.

Consensus: Botulinum Toxin Type A--Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications.

Plast Reconstr Surg. 2016 Mar;137(3):518e–529e.

jaad.2019.11.042

[4] Nawrocki S, Cha J. Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis. J Am Acad Dermatol [Internet]. [cited 2020 Feb 7]; Available from: https://doi.org/10.1016/j.

[5] Lowe NJ. Aesthetic Uses of

of Dermatology, Ninth Edition [Internet]. Ninth Edition. Wiley-Blackwell; 2016. Available from: https://onlinelibrary.wiley.com/doi/ abs/10.1002/9781118441213.rtd0036

New York: ELSEVIER; 2017.

[7] Kwon K-H, Shin KS, Yeon SH, Kwon DG. Application of botulinum toxin in maxillofacial field: part I. Bruxism and square jaw. Maxillofac Plast Reconstr Surg. 2019 Oct 1;41(1):38-38.

[8] Giordano CN, Matarasso SL, Ozog DM. Injectable and topical

Botulinum Toxins. In: Rook's Textbook

[6] Carruthers A, Carruthers J, Trindade de Almeida A. Botulinum Toxin. In: Dermatology: 4th Edition. 4th Edition.

[3] Sundaram H, Signorini M, Liew S, Trindade de Almeida AR, Wu Y, Vieira Braz A, et al. Global Aesthetics

*DOI: http://dx.doi.org/10.5772/intechopen.94495*

neurotoxins in dermatology: Indications, adverse events, and controversies. J Am Acad Dermatol.

2017 Jun 1;76(6):1027-1042.

[9] Klein FH de M de S, Brenner FM, Sato MS, Robert FMBR, Helmer KA. Lower facial remodeling with botulinum

toxin type A for the treatment of masseter hypertrophy. An Bras Dermatol. 2014;89(6):878-884.

[10] Cooper L, Lui M, Nduka C. Botulinum toxin treatment for facial palsy: A systematic review. J Plast Reconstr Aesthet Surg. 2017 Jun

[11] Monini S, De Carlo A, Biagini M, Buffoni A, Volpini L, Lazzarino AI, et al. Combined protocol for treatment of secondary effects from facial nerve palsy. Acta Otolaryngol (Stockh). 2011

[12] Shuo L, Ting Y, KeLun W, Rui Z, Rui Z, Hang W. Efficacy and possible mechanisms of botulinum toxin treatment of oily skin. J Cosmet Dermatol. 2019 Apr 1;18(2):451-457.

Randomized, Placebo-Controlled Study to Determine the Safety and the Efficacy of Using Botulinum Neurotoxin Type A Injections for Subjects With Mild to Moderate Acne Vulgaris [Internet]. clinicaltrials.gov; 2018 May [cited 2020 Jun 4]. Report No.: NCT00765375. Available from: https://clinicaltrials.

[14] Freni F, Gazia F, Stagno d'Alcontres F, Galletti B, Galletti F. Use of botulinum toxin in Frey's syndrome. Clin Case Rep.

[15] Bae GY, Yune YM, Seo K, Hwang SI. Botulinum Toxin Injection for Salivary Gland Enlargement Evaluated Using Computed Tomographic Volumetry.

[13] Dayan SH. Double-Blind,

gov/ct2/show/NCT00765375

2019 Jan 31;7(3):482-485.

1;70(6):833-841.

Aug 1;131(8):882-886.
